Investigating how changes in polyamine metabolism can help treat genetic disorders.
Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disorders
This study is looking at how changes in certain genes can cause conditions like Bachmann-Bupp Syndrome and Snyder-Robinson Syndrome, and it aims to find out if treatments can help balance important substances in the body to improve symptoms for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-11031306 on NIH RePORTER |
What this research studies
This research focuses on understanding how mutations in genes related to polyamine metabolism can lead to neurodevelopmental disorders, specifically Bachmann-Bupp Syndrome and Snyder-Robinson Syndrome. The researchers aim to explore the biochemical pathways affected by these mutations and how they can be targeted for therapeutic intervention. By using a combination of in vitro studies, animal models, and clinical data, they will investigate whether pharmacological treatments can normalize polyamine levels and alleviate symptoms in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Bachmann-Bupp Syndrome or Snyder-Robinson Syndrome, particularly those with identified mutations in the relevant genes.
Not a fit: Patients with neurodevelopmental disorders not linked to polyamine metabolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve the quality of life for patients with specific genetic disorders.
How similar studies have performed: Previous research has shown promising results in targeting polyamine metabolism for therapeutic benefits in related conditions, suggesting potential for success in this approach.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Bachmann, Andre S — Michigan State University
- Study coordinator: Bachmann, Andre S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.